CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $963,000 | +324.2% | 18,643 | +103.9% | 0.01% | +250.0% |
Q2 2022 | $227,000 | -9.6% | 9,141 | -8.6% | 0.00% | +100.0% |
Q1 2022 | $251,000 | -24.6% | 9,999 | +9.2% | 0.00% | 0.0% |
Q4 2021 | $333,000 | +20.7% | 9,158 | +70.3% | 0.00% | -50.0% |
Q1 2021 | $276,000 | +1.5% | 5,379 | +22.5% | 0.00% | 0.0% |
Q4 2020 | $272,000 | +6700.0% | 4,390 | +683.9% | 0.00% | – |
Q1 2014 | $4,000 | +33.3% | 560 | 0.0% | 0.00% | – |
Q4 2013 | $3,000 | -75.0% | 560 | -73.1% | 0.00% | – |
Q3 2013 | $12,000 | -25.0% | 2,084 | +82.8% | 0.00% | – |
Q2 2013 | $16,000 | – | 1,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |